PubMed

Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease.

Kalhs P, Panzer S, Kletter K, Minar E, Stain-Kos M, Walter R, Lechner K, Hinterberger W.

Ann Intern Med. 1988 Sep 15;109(6):461-4.PMID: 3046449 [PubMed - indexed for MEDLINE]Related articles

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF, Weiss M, Cohen A, Nekolla E, Kolb HJ.

Ann Intern Med. 1997 Feb 1;126(3):184-92.PMID: 9027268 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.

Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D.

Biol Blood Marrow Transplant. 2003 Jan;9(1):52-9.PMID: 12533742 [PubMed - indexed for MEDLINE]Related articles

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, Shore TB, Walker IR, Browett P, Messner HA, Panzarella T, Lipton JH; Canadian Bone Marrow Transplant Group.

Blood. 2002 Sep 1;100(5):1525-31.PMID: 12176866 [PubMed - indexed for MEDLINE]Related articlesFree article

Functional asplenia in patients with chronic graft-versus-host disease: concise communication.

Al-Eid MA, Tutschka PJ, Wagner HN Jr, Santos GW, Tsan MF.

J Nucl Med. 1983 Dec;24(12):1123-6.PMID: 6358431 [PubMed - indexed for MEDLINE]Related articlesFree article

Functional hyposplenism following allogeneic bone marrow transplantation.

Cuthbert RJ, Iqbal A, Gates A, Toghill PJ, Russell NH.

J Clin Pathol. 1995 Mar;48(3):257-9.PMID: 7730489 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.

Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Löwenberg B, Cornelissen JJ.

Exp Hematol. 2005 Aug;33(8):912-9.PMID: 16038784 [PubMed - indexed for MEDLINE]Related articles

Functional asplenia after bone marrow transplantation.

Kalhs P, Kier P, Lechner K.

Ann Intern Med. 1990 Nov 15;113(10):805-6. No abstract available. PMID: 2240887 [PubMed - indexed for MEDLINE]Related articles

Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.

Kolb HJ, Socié G, Duell T, Van Lint MT, Tichelli A, Apperley JF, Nekolla E, Ljungman P, Jacobsen N, van Weel M, Wick R, Weiss M, Prentice HG.

Ann Intern Med. 1999 Nov 16;131(10):738-44.PMID: 10577296 [PubMed - indexed for MEDLINE]Related articlesFree article

Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course.

Clark JG, Crawford SW, Madtes DK, Sullivan KM.

Ann Intern Med. 1989 Sep 1;111(5):368-76.PMID: 2669592 [PubMed - indexed for MEDLINE]Related articles

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E.

N Engl J Med. 2000 Jun 22;342(25):1846-54.PMID: 10861319 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.

Dominietto A, Raiola AM, van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Frassoni F, Casarino L, Verdiani S, Bacigalupo A.

Br J Haematol. 2001 Jan;112(1):219-27.PMID: 11167808 [PubMed - indexed for MEDLINE]Related articles

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ.

Blood. 2002 Jul 15;100(2):415-9.PMID: 12091330 [PubMed - indexed for MEDLINE]Related articlesFree article

Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Gratwohl A, Hermans J, van Biezen A, Arcese W, Debusscher L, Ernst P, Ferrant A, Frassoni F, Gahrton G, Iriondo A, Kolb HJ, Link H, Niederwieser D, Ruutu T, Siegert W, Zwaan FE.

Br J Haematol. 1996 Dec;95(3):494-500.PMID: 8943890 [PubMed - indexed for MEDLINE]Related articles

One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

Mengarelli A, Iori AP, Romano A, Cerretti R, Cerilli L, De Propris MS, Fenu S, Moleti ML, De Felice L, Girelli G, Arcese W.

Haematologica. 2003 Mar;88(3):315-23.PMID: 12651271 [PubMed - indexed for MEDLINE]Related articlesFree article

Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.

Colombo AA, Rusconi C, Esposito C, Bernasconi P, Caldera D, Lazzarino M, Alessandrino EP.

Transplantation. 2006 Apr 27;81(8):1087-92.PMID: 16641591 [PubMed - indexed for MEDLINE]Related articles

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

Enright H, Davies SM, DeFor T, Shu X, Weisdorf D, Miller W, Ramsay NK, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P.

Blood. 1996 Jul 15;88(2):714-20.PMID: 8695820 [PubMed - indexed for MEDLINE]Related articlesFree article

A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.

Ustün C, Arslan O, Beksaç M, Koç H, Gürman G, Ozçelik T, Yilmaz B, Ilhan O, Akan H, Ozcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek I, Celebi H, Coskun HS.

Biol Blood Marrow Transplant. 1999;5(1):28-35.PMID: 10232738 [PubMed - indexed for MEDLINE]Related articles

Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.

Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ.

Biol Blood Marrow Transplant. 2002;8(5):261-7.PMID: 12064363 [PubMed - indexed for MEDLINE]Related articles

A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.

Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift RA, Storb R, Buckner CD, Appelbaum FR, Hansen JA, Sullivan KM.

Blood. 1995 Sep 1;86(5):2028-32.PMID: 7655031 [PubMed - indexed for MEDLINE]Related articlesFree article